BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 13, 2018
View Archived Issues
Synthesis method enables functional studies identifying antibiotic's promise
Read More
Researchers present preclinical data for PDE4B inhibitor VFP-B-3
Read More
ZHX2 acts as oncoprotein in clear cell renal carcinoma
Read More
Humanized midkine antibody demonstrates efficacy in experimental model of FSGS
Read More
First patient dosed in phase III clinical program for APL-2 in geographic atrophy
Read More
FDA approves initiation of phase II PHAST-TSC study for treatment of acute stroke
Read More
RedHill Biopharma concludes positive end-of-phase II meeting with FDA on Bekinda for IBS-D
Read More
New data support use of Akari Therapeutics' Coversin in inflammatory diseases
Read More
ORAIP: a potential biomarker of CTEPH
Read More
NIAID grant supports TechnoVax's development of universal influenza vaccine
Read More
Progenics reports topline phase III data on 1404 in low-grade prostate cancer
Read More
Verseon initiates phase I trial with anticoagulant VE-1902
Read More
University of Florida patents vincamine analogues
Read More
NIAAA to conduct phase II study of ANS-6637 for alcohol use disorder
Read More
TXNDC5 as a novel modulator of endothelial dysfunction and atherosclerosis
Read More
Galapagos and AbbVie Sarl present CFTR mutant correctors
Read More
Ono Pharmaceutical and Gilead Sciences identify new BTK inhibitors
Read More
First phase II data presented for AZD-4017 in idiopathic intracranial hypertension
Read More
Eisai divulges new hSTING agonists for cancer
Read More
Overcoming the biomolecular corona by pre-adsorption of antibodies to nanocarriers surface
Read More
Results of a first-in-human study of the JAK 1 inhibitor PF-04965842 in healthy subjects
Read More